Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/13/2023 | $165.00 | Buy | DA Davidson |
| 7/18/2023 | Outperform | William Blair | |
| 5/2/2023 | $140.00 | Outperform | Barrington Research |
| 1/27/2023 | $150.00 | Buy | The Benchmark Company |
| 5/9/2022 | Mkt Perform → Outperform | William Blair | |
| 8/16/2021 | $113.00 → $133.00 | Outperform | Barrington Research |
10-Q - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Filer)
8-K - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Filer)
8-K - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Filer)
SALEM, N.H., Nov. 14, 2024 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) today announced that it has acquired Michigan-based Custom Biogenic Systems ("CBS") for approximately $6.2 million in cash. The transaction is being financed from Standex's existing cash balance. In its first year of ownership, the Company expects the acquisition to be accretive to its earnings. CBS will be reported as part of Standex's Scientific business segment. "We are pleased to have acquired Custom Biogenic Systems, extending the reach of our scientific refrigeration business with a p
Northern Edge Advisors served as the exclusive financial advisor to privately-held US-based Amran Instrument Transformers and India-based Narayan Powertech Pvt. Ltd. ("Amran/Narayan Group") in the sale to Standex International Corporation (NYSE:SXI). Structured as the simultaneous sale of two separate companies, the acquisitions are the largest in Standex's history, with a combined enterprise value of approximately $462 million consisting of both cash and stock consideration. The international nature of the transactions introduced myriad technical challenges due to differing regulatory and legal regimes, as well as logistical challenges working across time zones. With manufacturing facili
Chamberlain Hrdlicka's M&A team, led by David Sheinbein, represented privately-held US-based Amran Instrument Transformers and India-based Narayan Powertech Pvt. Ltd ("Amran/Narayan Group") in two simultaneous sale transactions to Standex International Corporation (NYSE:SXI). With manufacturing locations in the United States and India and customers in more than 60 countries, Amran/Narayan Group is a leading manufacturer and distributor of low-voltage and medium-voltage instrument transformers and other products focused on the electrical grid, smart grid technology, data centers, and renewable energy systems. The company's products are used in many electrical grid applications, supporting m
DA Davidson initiated coverage of Standex International with a rating of Buy and set a new price target of $165.00
William Blair resumed coverage of Standex International with a rating of Outperform
Barrington Research resumed coverage of Standex International with a rating of Outperform and set a new price target of $140.00
SC 13G - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Subject)
SC 13G/A - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Subject)
SC 13G/A - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Subject)
4 - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Issuer)
4 - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Issuer)
4 - STANDEX INTERNATIONAL CORP/DE/ (0000310354) (Issuer)
6 analysts have expressed a variety of opinions on Standex International (NYSE:SXI) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 2 0 0 0 Last 30D 0 1 0 0 0 1M Ago 3 1 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $193.83, a high estimate of $210.00, and a low estimate of $180.00. Marking an increase of 5.92%, the
Barrington Research analyst Gary Prestopino maintains Standex International (NYSE:SXI) with a Outperform and maintains $180 price target.
SALEM, N.H., Oct. 17, 2022 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) today announced the appointment of Christopher Howe to the position of Standex Director of Investor Relations, effective October 12, 2022. Howe is a seasoned equity analyst with almost a decade of experience covering diversified industrials and industrial technology companies. He holds an M.B.A in financial analysis from DePaul University's Kellstadt Graduate School of Business, where he graduated with distinction. As Standex Director of Investor Relations, Howe will be responsible for mana
CLEVELAND, May 03, 2022 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE:PH), the global leader in motion and control technologies, today announced that Robin J. Davenport, Vice President - Corporate Finance, will retire effective December 31, 2022, after 19 years of dedicated service to the company. "Robin should take pride in all she has accomplished throughout her career and nearly two decades with Parker," said Todd Leombruno, Executive Vice President and Chief Financial Officer. "As a corporate finance leader, Robin not only served as Parker's primary contact to the investment community but helped lead the company through several phases of growth and expansion, navigate perio
SALEM, N.H., May 6, 2021 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) today announced that it has appointed Robin J. Davenport, Vice President of Corporate Finance, at Parker-Hannifin Corporation as an observer and advisor to its Board of Directors, and intends to nominate Ms. Davenport for election to the Board of Directors at Standex's 2021 Annual Shareholders Meeting. "We are delighted that Robin has agreed to serve on the Standex Board of Directors. She is a highly accomplished and respected executive with comprehensive financial and global industry exp
SALEM, N.H., Nov. 14, 2024 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) today announced that it has acquired Michigan-based Custom Biogenic Systems ("CBS") for approximately $6.2 million in cash. The transaction is being financed from Standex's existing cash balance. In its first year of ownership, the Company expects the acquisition to be accretive to its earnings. CBS will be reported as part of Standex's Scientific business segment. "We are pleased to have acquired Custom Biogenic Systems, extending the reach of our scientific refrigeration business with a p
Sales Declined 7.7% with Contributions from Acquisitions Partially Offsetting Organic DeclineRecord GAAP and Adjusted Gross Margin of 41.1%; Up 240 bps Sequentially and 160 bps YOYGAAP Operating Margin of 14.1%; Adjusted Operating Margin of 15.9%Acquired Amran Instrument Transformers & Narayan Powertech Pvt., Ltd., Largest Acquisition in Company's History; Significantly Expands Presence in Fast-Growing, High-Margin Electrical Grid End Market; Expected to be Immediately Accretive to Revenue Growth, Margins, and EPSSALEM, N.H., Oct. 29, 2024 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) today reported financial results for the first quarter of fiscal year 2025 ended September 30
Immediately Accretive to Revenue Growth, EBITDA Margin, Operating Margin, EPS and FCFAmran/Narayan Grew Revenue at ~30% CAGR Over Last Three Years; Expects ~$100M of Revenue in CY 2024, with Adjusted EBITDA Margin Above 40%Significantly Expands Presence in the Fast-Growing, High-Margin Electrical Grid End Market, Benefiting from Infrastructure Upgrades, Capacity Expansion and Data Center DemandStandex's Exposure to Fast Growth Markets Increases to ~25% of Sales on Pro-Forma FY 2024 BasisBroadens Technology Platform and Capabilities to Expand Growth into Electronics' MarketsGeographic Expansion with Engineering Expertise in India and Intellectual Property in Low to Medium Voltage Technologies